According to the research report titled ‘GLOBAL DNA SEQUENCING MARKET 2021-2028,’ available with MarketStudyReport, global DNA sequencing market is slated to expand at 4.62% CAGR during the period 2021-2028.

The heightened prevalence of cancer diseases, widespread application of DNA sequencing for animal & plants reproduction, and massive advancement in DNA technology are factors stimulating the global DNA sequencing market growth.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/3855565/  

Moreover, the rise in genome mapping programs, combined with extensive R&D activities in DNA sequencing are poised to create profit-making opportunities for the enterprises in this domain during the forecast period 2021-2028.

Even so, a dearth of skilled professionals, limitations in diagnostic testing, and challenges with bioinformatics are likely to restrict the progress of market in the forthcoming years.

In terms of technology type, the market is categorized into nanopore sequencing, sequencing by synthesis, single-molecule real-time sequencing (SMRT), ion semiconductor sequencing, sequencing by ligation (SBL), chain termination sequencing, pyrosequencing, and others.

Based on application scope, worldwide DNA sequencing industry is divided into forensics, biomarker discovery, agriculture & animal research, diagnostics, drug discovery, reproductive health, personalized medicine, and others.

As for industry verticals, the business sphere is classified into hospitals & clinics, pharmaceuticals, biotechnology companies, research centers, academic & government institutes, and others. Meanwhile, the various product types include bioinformatics, sequencing services, and instruments & consumables.

From a regional standpoint, Asia Pacific market is estimated to exhibit a substantial growth rate during the assessment timeframe, owing to the widespread application of technology in sectors like agriculture and animal breeding, which contribute immensely towards the economic development of countries like India, China, and South Korea.

The established names in the global DNA sequencing industry include Bio-Rad Laboratories Inc., Agilent Technologies Inc., Spiral Genetics Inc., Eurofins Scientific, Asuragen Inc., BGI Group, Siemens Healthineers AG, Adaptive Biotechnologies Inc., Pacific Biosciences of California Inc., Illumina Inc., Danaher Corporation, Merck Group, F. Hoffmann-La Roche, PerkinElmer Inc., and Thermo Fisher Scientific Inc. among others.